-

CALL US AT

( +1 ) 877-441-4866


Get a Call from us

call-icon
Companion Animal Health Market

Global Companion Animal Health Market – Forecasts 2019-2026

SKU: DAH6 | Last Updated On: 2019-04-09 | No. of Pages: 225 | Available Formats

( 22 Samples have been requested. )
In April 2019, Boehringer Ingelheim launched first-ever stem cell-based veterinary medicine Arti-Cell Forte to treat equine lameness.

Companion Animal Health Market

Companion animals are domesticated or domestic-bred animals whose physical, emotional, behavioral and social needs can be readily met as companions in the home, or in close daily relationship with humans. Companion animals play an important role in the lives of many people by providing a sense of belonging and responsibility. The most popular pets are cats and dogs. In most of the economies, the disposable income of families has increased which has enabled people to adopt pet animals and spend on their healthcare. According to World Organization for Animal Health, the adoption of pets in India has risen from 8 million to 13 million from 2010 to 2018, and this trend is most likely to continue in coming 6-7 years, resulting in continuous demand for various pet animal healthcare products and contribute to total animal healthcare industry size.

Various types of diseases in animals and their transfer to humans via their product consumption and companionship are escalating all over the world. Pet owners insist that their pets should lead the same healthy lifestyles like them. Governments across the globe have initiated animal vaccination programs and made vaccination a mandate. The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) is engaged in preventing, tracking, detecting, and responding to outbreaks of infectious diseases in the U.S. and other countries. In animal health products, feeds are the most commonly used products for animal healthcare. It also includes pharmaceuticals and vaccines, which contribute significantly to the health and wellbeing of these animals. These products provide nutrition to animals.

The global companion animal health market will exhibit a CAGR of 5.7% from 2019 to 2026, having an estimated market value of US $ XX billion by 2026.

 

Companion Animal Health Market Dynamics

The major drivers fueling the growth of the market are growing human-animal bond, which defines consumers’ willingness to spend more money for their pets, increasing the prevalence of zoonotic diseases and efforts undertaken by various animal welfare organizations at the country and regional levels.

Over the last decade progress in biomedical research, virology and microbiology have also fueled the innovation of vaccine research, including a better understanding of the interaction between pathogens and the host immune system, the continuous improvement in the deciphering of the immune response and its components in domestic animals.

Steps taken by many government and non-government organizations like International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) that is a trilateral European Union-Japan-US program aimed at harmonizing technical requirements for veterinary product registration. The role of VICH is to harmonize technical requirements for data necessary for the marketing authorization of a veterinary medicinal product. This is achieved by developing harmonized guidelines on the studies to be submitted in a marketing authorization application.

Changes in distribution channels and increasing cost of animal testing and veterinary services are going to restrain the market in the forecast period.

Generally, companion animal owners purchase their animal health products directly from veterinarians and veterinarians recommend low-cost generic product subtitles. Even there are several restrictions and regulations on animal testing worldwide, which is hindering a number of healthcare companies from manufacturing newly advanced drugs. Also, because of the increasing regulations, animal testing is becoming expensive.


Companion Animal Health Segmentation Analysis

The market is segmented by products as Vaccines, Anti-Infectives, Medicinal Feed Additives, Parasiticides, Diagnostics, and Others and by animals like cats, dogs, equine and others.

Parasiticides had a dominant market share in 2018 of more than 25% because of an increase in flea and tick-infested Lyme disease in dogs and cats. According to NCEZID, around 32% of the pets at some point in their life suffers from flea and ticks. Parasiticides are medicinal substances that prevent the spread of internal and external parasites in companion animals. These are effective against flea and tick infestations and internal parasites like heartworms inside companion animals. Companies are focused on product launch and development of existing parasiticides products. Vetoquinol has developed Flevox, a parasiticide for companion animals fighting against tick and flea infestation in pets.

Dogs accounted for the largest share of the animal type segment of more than 60% owing to health benefits associated with the adoption of pets, an increase in awareness, and demand for efficient care for dogs. Healthcare problems in dogs include heartworm (parasitic worm in pulmonary arteries of dogs), kennel cough, parvovirus, Lyme disease, demodectic mange (an inflammatory disease that leads to skin lesions and hair loss) and ringworm. Complex diseases in canines can be identified early by diagnostics or prevented altogether by application of vaccines. Increased awareness about healthcare products from the owners’ side has driven canine healthcare market. Companies are focused on developing products which are easy to apply. For instance, in 2012, Bayer Healthcare developed Resultix, a spray-on formula that kills attached or crawling ticks on a dog’s body.


  • The significant restraint to the canine healthcare market is the unwillingness on the part of the owners to spend a substantial amount of money on canines after a certain point of time. Companies are focused on developing products which are easy to apply.
  • For instance, Bayer Healthcare developed Resultix, a spray-on formula that kills attached or crawling ticks on a dog’s body.

 

Global Companion Animal Health Regional Share

Geographically, the global Companion Animal Health market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.

North America accounts for the highest market share of around 40% globally, because of the large adoption of animals and the growing incidence of zoonotic and food-borne diseases is a potential concern for the health of pet animals. In many countries such as the U.S., brucellosis is increasing and causes abortion in animals. Americans view pets as more than just companion animals. Almost all dog and cat owners view their pets as members of their family (95%), and about 12% have pet health insurance. According to Labor Statistics, 84.6 million households own pets and spend around $ 892 per year on pets.

Europe has the second largest market in the world with more than 25% of the market share. In Germany, animal health is secured by legislation and the veterinary administration. As animal diseases do not stop at national borders, the Federal Ministry works continuously with the veterinary authorities of the other Member States and third countries. Similarly, a new EU Animal Health Law, which is due to introduce will provide additional animal health requirements - including provisions on pet travel - across the EU from 2021.

 

Companion Animal Health Companies

Some of the major key players are Merck Animal Health, Ceva Sante Animale, Vetaquinol SA, Nutreco N.V., Bayer Healthcare, Virbac, Boehringer Ingelheim, Zoetis, Elanco and Ameri-Pac Inc.

Boehringer Ingelheim, Zoetis, Bayer Healthcare, Merck, and Virbac holds a major market share in the global companion animal health market that accounts for more than 40% of the market. Boehringer Ingelheim is the market leader with more than 20% of the total market followed by Zeotis, Bayer Healthcare, and Merck. Boehringer Ingelheim became a market leader with the acquisition of Sanofi’s animal-health business (Merial). The acquisition of Merial makes Boehringer Ingelheim the second-largest animal health company in the world. The U.S. animal-health market will be the largest for Boehringer Ingelheim, representing more than 40% of annual sales.

  • In Aug 2018, Virbac launched new VeggieDent FR3SH Dental Chews to target the causes of halitosis in dogs.
  • In Aug 2018, FDA approved NexGard® (afoxolaner) for the prevention of infections that cause Lyme disease in dogs.
  • In June 2018, Wageningen Bioveterinary Research (WBVR) and Ceva Santé Animale (Ceva) announced a new collaboration to develop veterinary vaccines for the control of (re)emerging infectious animal diseases, such as Rift Valley fever and Influenza.
  • In June 2018, Avivagen received approval from Health Canada for the use of OxC-beta™ in Companion Animal Supplements.
  • In Jan 2018, Rhone Ma Holdings Bhd via its unit Rhone Ma Malaysia Sdn Bhd entered a joint venture with CEVA Sante Animale S.A. for the exclusive distribution of the latter's animal health products such as vaccines for companion animal, poultry, ruminant and swine.

 

Reasons for purchasing this report?

• Visualize the composition of the global companion animal health market products across each indication, regarding products and animals highlighting the critical commercial assets and players.

• Identify business opportunities in the companion animal health products market by analyzing trends and co-development deals.

• Excel data sheet with thousands of data points of the companion animal health products levels 4/5 segmentation.

• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

• Product mapping in excel for the essential products of all major market players.


Who can benefit from this report?

• Raw Material Suppliers/ Buyers

• Product Suppliers/ Buyers

• Industry Investors/Investment Bankers

• Education & Research Institutes

• Research Professionals

• Emerging Companies

• Manufacturers

Global Companion Animal Health Market

1. Global Companion Animal Health Market Methodology and Scope

1.1 Research Methodology

1.2 Research Objective and Scope of the Report

2. Global Companion Animal Health Market – Market Definition and Overview

3. Global Companion Animal Health Market – Executive Summary

3.1 Market Snippet by Products

3.2 Market Snippet by Animals

3.3 Market Snippet by Region

3.4 DataM CLO Scenario

4. Global Companion Animal Health Market – Market Dynamics

4.1 Market Impacting Factors

4.1.1 Drivers

4.1.1.1 Increasing number of companion animal ownership

4.1.1.2 Advances in animal health medicines and vaccines

4.1.1.3 Increasing initiatives by government and animal welfare associations

4.1.2 Restraints

4.1.2.1 Changes in distribution channel might hamper the market growth

4.1.2.2 Increasing cost of animal testing and veterinary services

4.1.3 Opportunity

4.1.4 Impact Analysis

5. Global Companion Animal Health Market – Industry Analysis

5.1 Porter's Five Forces Analysis

5.2 Supply Chain Analysis

5.3 Regulatory Analysis

5.4 Epidemiology

6. Global Companion Animal Health Market – By Products

6.1 Introduction

6.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products Segment

6.1.2 Market Attractiveness Index, By Products Segment

6.2 Vaccines

6.2.1 Introduction

6.2.2 Market Size Analysis, and Y-o-Y Growth Analysis (%)

6.3 Anti-Infectives

6.4 Medicinal Feed Additives

6.5 Parasiticides

6.6 Diagnostics

6.7 Others    

7. Global Companion Animal Health Market – By Animals

7.1 Introduction

7.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals

7.1.2 Market Attractiveness Index, By Animals

7.2 Cats

7.2.1 Introduction

7.2.2 Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

7.3 Dogs

7.4 Equine

7.5 Others

8. Global Companion Animal Health Market – By Region

8.1 Introduction

8.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

8.1.2 Market Attractiveness Index, By Region

8.2 North America

8.2.1 Introduction

8.2.2 Key Region-Specific Dynamics

8.2.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products

8.2.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals

8.2.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.2.5.1 U.S.

8.2.5.2 Canada

8.2.5.3 Mexico

8.3 Europe

8.3.1 Introduction

8.3.2 Key Region-Specific Dynamics

8.3.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products

8.3.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals

8.3.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.3.5.1 Germany

8.3.5.2 U.K.

8.3.5.3 France

8.3.5.4 Italy

8.3.5.5 Spain

8.3.5.6 Rest of Europe

8.4 South America

8.4.1 Introduction

8.4.2 Key Region-Specific Dynamics

8.4.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products

8.4.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals

8.4.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.4.5.1 Brazil

8.4.5.2 Argentina

8.4.5.3 Rest of South America

8.5 Asia Pacific

8.5.1 Introduction

8.5.2 Key Region-Specific Dynamics

8.5.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products

8.5.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals

8.5.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.5.5.1 China

8.5.5.2 India

8.5.5.3 Japan

8.5.5.4 Australia

8.5.5.5 Rest of Asia Pacific

8.6 Middle East and Africa

8.6.1 Introduction

8.6.2 Key Region-Specific Dynamics

8.6.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Products

8.6.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animals

9. Global Market – Competitive Landscape

9.1 Competitive Scenario

9.2 Competitor Companion Animal Health Strategy Analysis

9.3 Comparative Product Portfolio Analysis

9.4 Market Positioning/Share Analysis

9.5 Mergers and Acquisitions Analysis

10. Company Profiles

10.1 Merck Animal Health

10.1.1 Company Overview

10.1.2 Product Portfolio and Description

10.1.3 Key Highlights

10.1.4 Financial Overview

10.2   Ceva Sante Animale

10.3   Vetaquinol SA

10.4   Nutreco N.V.

10.5   Bayer Healthcare

10.6   Virbac

10.7   Boehringer Ingelheim

10.8   Zoetis

10.9   Elanco

10.10 Ameri-Pac Inc.

11. Global Companion Animal Health Market – Premium Insights

12. Global Companion Animal Health Market – DataM

12.1   Appendix

12.2   About Us and Services

12.3   Contact Us

LIST OF TABLES

TABLE 01.   GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE, 2018, 2022 & 2026 ($ MN), BY PRODUCT TYPE

TABLE 02.   GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE 2018, 2022 & 2026 ($ MN), BY ANIMALS

TABLE 03.   GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE 2018, 2022 & 2026 ($ MN), BY REGION

TABLE 04.   GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE 2018, 2022 & 2026 (%), BY PRODUCT TYPE

TABLE 05.   GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 06.   GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE 2018, 2022 & 2026 (%), BY ANIMALS

TABLE 07.   GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY ANIMALS, 2018–2026

TABLE 08.   GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE 2018, 2022 & 2026 (%), BY REGION

TABLE 09.   GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY REGION, 2018–2026

TABLE 10.   NORTH AMERICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 11.   NORTH AMERICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY ANIMALS, 2018–2026

TABLE 12.   NORTH AMERICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY COUNTRY, 2018–2026

TABLE 13.   SOUTH AMERICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 14.   SOUTH AMERICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY ANIMALS, 2018–2026

TABLE 15.   SOUTH AMERICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY COUNTRY, 2018–2026

TABLE 16.   EUROPE COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 17.   EUROPE COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY ANIMALS, 2018–2026

TABLE 18.   EUROPE COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY COUNTRY, 2018–2026

TABLE 19.   ASIA PACIFIC COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 20.   ASIA PACIFIC COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY ANIMALS, 2018–2026

TABLE 21.   ASIA PACIFIC COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY COUNTRY, 2018–2026

TABLE 22.   MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 23.   MIDDLE EAST & AFRICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY ANIMALS, 2018–2026

TABLE 24.  MERCK ANIMAL HEALTH: OVERVIEW

TABLE 25.  MERCK ANIMAL HEALTH: PRODUCT PORTFOLIO

TABLE 26.  MERCK ANIMAL HEALTH: KEY DEVELOPMENTS

TABLE 27.   CEVA SANTE ANIMALE: OVERVIEW

TABLE 28.   CEVA SANTE ANIMALE: PRODUCT PORTFOLIO

TABLE 29.   CEVA SANTE ANIMALE: KEY DEVELOPMENTS

TABLE 30.   VETOQUINOL S.A.: OVERVIEW

TABLE 31.   VETOQUINOL S.A.: PRODUCT PORTFOLIO

TABLE 32.   VETOQUINOL S.A.: KEY DEVELOPMENTS

TABLE 33.   NUTRECO N.V.: OVERVIEW

TABLE 34.   NUTRECO N.V.: PRODUCT PORTFOLIO

TABLE 35.   NUTRECO N.V.: KEY DEVELOPMENTS

TABLE 36.   BAYER HEALTHCARE LLC: OVERVIEW

TABLE 37.   BAYER HEALTHCARE LLC: PRODUCT PORTFOLIO

TABLE 38.   BAYER HEALTHCARE LLC: KEY DEVELOPMENTS

TABLE 39.   VIRBAC: OVERVIEW

TABLE 40.   VIRBAC: PRODUCT PORTFOLIO

TABLE 41.   VIRBAC: KEY DEVELOPMENTS

TABLE 42.   BOEHRINGER INGELHEIM: OVERVIEW

TABLE 43.   BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO

TABLE 44.   BOEHRINGER INGELHEIM: KG: KEY DEVELOPMENTS

TABLE 45.   ZOETIS: OVERVIEW

TABLE 46.   ZOETIS: PRODUCT PORTFOLIO

TABLE 47.   ZOETIS: KEY DEVELOPMENTS

TABLE 48.   ELANCO: OVERVIEW

TABLE 49.   ELANCO: PRODUCT PORTFOLIO

TABLE 50.   ELANCO: KEY DEVELOPMENTS

TABLE 51.   AMERI-PAC INC.: OVERVIEW

TABLE 52.   AMERI-PAC INC.: PRODUCT PORTFOLIO

TABLE 53.   AMERI-PAC INC.: KEY DEVELOPMENTS


LIST OF FIGURES

FIGURE 01.   GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE, 2018 & 2026 (%), BY PRODUCT TYPE

FIGURE 02.   GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE, 2018 & 2026 (%), BY ANIMALS

FIGURE 03.   GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE, 2018 & 2026 (%), BY REGION

FIGURE 04.   GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE, 2018 - 2026 ($ MN) AND YEAR ON YEAR GROWTH

FIGURE 05.   GLOBAL COMPANION ANIMAL HEALTH MARKET YEAR ON YEAR GROWTH 2018 TO 2026 (%), BY PRODUCT TYPE

FIGURE 06.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY VACCINES PRODUCT TYPE, 2018–2026

FIGURE 07.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY ANTI-INFECTIVES PRODUCT TYPE, 2018–2026

FIGURE 08.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY MEDICINAL FEED ADDITIVES PRODUCT TYPE, 2018–2026

FIGURE 09.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY PARASITICIDES PRODUCT TYPE, 2018–2026

FIGURE 10.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY DIAGNOSTICS PRODUCT TYPE, 2018–2026

FIGURE 11.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY OTHERS PRODUCT TYPE, 2018–2026

FIGURE 12.    GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT TYPE, 2018 & 2026

FIGURE 13.   GLOBAL COMPANION ANIMAL HEALTH MARKET YEAR ON YEAR GROWTH 2018 TO 2026 (%), BY ANIMALS

FIGURE 14.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY CATS ANIMALS, 2018–2026

FIGURE 15.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY DOGS ANIMALS, 2018–2026

FIGURE 16.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY EQUINE ANIMALS APPLICATION, 2018–2026

FIGURE 17.    GLOBAL COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), BY OTHERS ANIMALS, 2018–2026

FIGURE 18.    GLOBAL COMPANION ANIMAL HEALTH MARKET SHARE (%), BY ANIMALS, 2018 & 2026

FIGURE 19.   GLOBAL COMPANION ANIMAL HEALTH MARKET YEAR ON YEAR GROWTH 2018 TO 2026 (%), BY REGION

FIGURE 20.    NORTH AMERICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), 2018–2026

FIGURE 21.    NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 22.    NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SHARE (%), BY ANIMALS, 2018–2026

FIGURE 23.   NORTH AMERICA COMPANION ANIMAL HEALTH MARKET SHARE (%), BY COUNTRIES, 2018–2026

FIGURE 24.    SOUTH AMERICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), 2018–2026

FIGURE 25.   SOUTH AMERICA COMPANION ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 26.   SOUTH AMERICA COMPANION ANIMAL HEALTH MARKET SHARE (%), BY ANIMALS, 2018–2026

FIGURE 27.    SOUTH AMERICA COMPANION ANIMAL HEALTH MARKET SHARE (%), BY COUNTRIES, 2018–2026

FIGURE 28.    EUROPE COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), 2018–2026

FIGURE 29.    EUROPE COMPANION ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 30.    EUROPE COMPANION ANIMAL HEALTH MARKET SHARE (%), BY ANIMALS, 2018–2026

FIGURE 31.    EUROPE COMPANION ANIMAL HEALTH MARKET SHARE (%), BY COUNTRIES, 2018–2026

FIGURE 32.    ASIA PACIFIC COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), 2018–2026

FIGURE 33.    ASIA PACIFIC COMPANION ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 34.    ASIA PACIFIC COMPANION ANIMAL HEALTH MARKET SHARE (%), BY ANIMALS, 2018–2026

FIGURE 35.    ASIA PACIFIC COMPANION ANIMAL HEALTH MARKET SHARE (%), BY COUNTRIES, 2018–2026

FIGURE 36.    MIDDLE EAST AND AFRICA COMPANION ANIMAL HEALTH MARKET VALUE ($ MN), 2018–2026

FIGURE 37.    MIDDLE EAST AND AFRICA COMPANION ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 38.    MIDDLE EAST AND AFRICA COMPANION ANIMAL HEALTH MARKET SHARE (%), BY ANIMALS, 2018–2026

FIGURE 39.   MERCK ANIMAL HEALTH: FINANCIALS

FIGURE 40.   CEVA SANTE ANIMALE: FINANCIALS

FIGURE 41.   VETOQUINOL S.A.: FINANCIALS

FIGURE 42.   NUTRECO N.V.: FINANCIALS

FIGURE 43.   BAYER HEALTHCARE LLC: FINANCIALS

FIGURE 44.   VIRBAC: FINANCIALS

FIGURE 45.    BOEHRINGER INGELHEIM: FINANCIALS

FIGURE 46.   ZOETIS: FINANCIALS

FIGURE 47.   ELANCO: FINANCIALS

FIGURE 48.   AMERI-PAC INC.: FINANCIALS

Buy This Report



INSTANT DELIVERY - 20% OFF

Could not find what you need?

Quick Fact: 7 of 10 customers Tailor their reports